Magnetar Financial’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History

Magnetar Financial’s Portfolio EUCRU Stock Details EUCRU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-392,001	Closed	-$3.93K	–	1804
2022 Q2	$3.93K	Sell	392,001 -57,999	-13%	-$576K	0.04%	376
2022 Q1	$4.45M	Sell	450,000 -657	-0.1%	-$6.52K	0.05%	396
2021 Q4	$4.5M	Sell	450,657 -4,000	-0.9%	-$40.2K	0.05%	411
2021 Q3	$4.53M	Hold	454,657	–	–	0.05%	393
2021 Q2	$4.63K	Buy	454,657 +4,657	+1%	+$46.8K	0.04%	394
2021 Q1	$4.54M	Sell	450,000 -50,000	-10%	-$533K	0.04%	365
2020 Q4	$5.25M	Buy	+500,000	New	+$5.08M	0.07%	242

Other funds holding EUCRU

Verition Fund Management

Verition Fund Management Greenwich, Connecticut $10.3B AUM 30.69% 1-Year Est. Return

Sio Capital Management New York $694M AUM 79.73% 1-Year Est. Return

Wealthspring Capital West Harrison, New York $421M AUM 9.46% 1-Year Est. Return

Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return

HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return

Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

HRT Financial New York $26B AUM 58.22% 1-Year Est. Return

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Wolverine Asset Management Chicago, Illinois $6.41B AUM 4.78% 1-Year Est. Return